SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 149 filers reported holding SERES THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $69,972 | -81.7% | 29,400 | -63.2% | 0.00% | – |
Q2 2023 | $382,400 | +70.4% | 79,833 | +101.7% | 0.00% | – |
Q1 2023 | $224,419 | -10.5% | 39,580 | -11.6% | 0.00% | – |
Q4 2022 | $250,818 | +5.8% | 44,789 | +34.7% | 0.00% | – |
Q1 2022 | $237,000 | -91.4% | 33,260 | -89.9% | 0.00% | – |
Q4 2021 | $2,756,000 | +85.5% | 330,787 | +55.0% | 0.00% | – |
Q3 2021 | $1,486,000 | -77.4% | 213,454 | -22.5% | 0.00% | -100.0% |
Q2 2021 | $6,568,000 | +39.6% | 275,410 | +20.5% | 0.00% | 0.0% |
Q1 2021 | $4,705,000 | +21.4% | 228,522 | +44.5% | 0.00% | 0.0% |
Q4 2020 | $3,875,000 | -3.9% | 158,135 | +11.0% | 0.00% | -33.3% |
Q3 2020 | $4,033,000 | +5830.9% | 142,435 | +894.2% | 0.00% | – |
Q2 2020 | $68,000 | +61.9% | 14,327 | +22.2% | 0.00% | – |
Q1 2020 | $42,000 | -78.8% | 11,722 | -79.6% | 0.00% | – |
Q4 2019 | $198,000 | -46.5% | 57,427 | -37.8% | 0.00% | -100.0% |
Q3 2019 | $370,000 | +0.3% | 92,348 | -19.5% | 0.00% | 0.0% |
Q2 2019 | $369,000 | – | 114,659 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 21,571,764 | $610,696,000 | 16.87% |
RA Capital Management | 4,750,000 | $134,473,000 | 2.46% |
ARK Investment Management | 12,293,033 | $348,016,000 | 2.06% |
Opaleye Management Inc. | 335,312 | $9,493,000 | 1.86% |
Sio Capital Management, LLC | 316,800 | $8,969,000 | 1.78% |
Ikarian Capital, LLC | 762,400 | $21,585,000 | 1.56% |
Nikko Asset Management Americas, Inc. | 5,531,670 | $152,176,000 | 1.35% |
EAM Global Investors LLC | 121,629 | $3,443,000 | 1.26% |
EAM Investors, LLC | 133,591 | $3,782,000 | 0.90% |
GILDER GAGNON HOWE & CO LLC | 3,185,420 | $90,179,000 | 0.56% |